Association Between Serum Cholesterol and Noncardiovascular Mortality in Older Age
- Autores: Rachel S. Newson, Janine F. Felix, Jan Heeringa, Albert Hofman, Jacqueline Witteman, Henning Tiemeier
- Localización: Journal of the American Geriatrics Society, ISSN 0002-8614, Vol. 59, Nº. 10, 2011, págs. 1779-1785
- Idioma: inglés
- Texto completo no disponible (Saber más ...)
-
Resumen
Objectives: To clarify the association between cholesterol and noncardiovascular mortality and to evaluate how this association varies across age groups.
Design: Prospective population-based cohort study.
Setting :Rotterdam, the Netherlands.
Participants: Adults aged 55 to 99 (N = 5,750).
Measurements: Participants were evaluated for total cholesterol and subfractions and followed for mortality for a median of 13.9 years. Total cholesterol and its subfractions were evaluated in relation to noncardiovascular mortality. Cox regression analyses were conducted in the total sample and within age-groups (55�64, 65�74, 75�84, ?85).
Results: Age- and sex-adjusted analyses showed that each 1-mmol/L increase in total cholesterol was associated with an approximately 12% lower risk of noncardiovascular mortality (hazard ratio (HR) = 0.88, 95% confidence interval (CI) = 0.84�0.92, P < .001). Age group�specific analyses demonstrated that this association reached significance after the age of 65 and increased in magnitude across each subsequent decade. This was driven largely by non-high-density lipoprotein cholesterol (non-HDL-C) (HR = 0.89, 95% CI 0.85�0.93, P < .001) and was partly attributable to cancer mortality. Conversely, HDL-C was not significantly associated with noncardiovascular mortality (HR = 0.92, 95% CI 0.79�1.07, P = .26).
Conclusion: Higher total cholesterol was associated with a lower risk of noncardiovascular mortality in older adults. This association varied across the late-life span and was stronger in older age groups. Further research is required to examine the mechanisms underlying this association.
